ABA Chemicals Corporation
300261.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -17.13 | -3.21 | 1.31 | -0.00 |
| FCF Yield | -0.06% | -0.04% | -1.04% | 0.86% |
| EV / EBITDA | 10,242.47 | 816.10 | -992.77 | -31.79 |
| Quality | ||||
| ROIC | 0.06% | 0.06% | -0.46% | -6.12% |
| Gross Margin | 23.47% | 17.85% | 20.81% | 11.37% |
| Cash Conversion Ratio | 10.89 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -5.70% | -10.13% | -12.50% | -15.67% |
| Free Cash Flow Growth | -34.26% | 95.37% | -215.71% | 765.32% |
| Safety | ||||
| Net Debt / EBITDA | 1,340.26 | 88.73 | -121.40 | -3.46 |
| Interest Coverage | -0.91 | 0.22 | -2.24 | -34.18 |
| Efficiency | ||||
| Inventory Turnover | 0.56 | 0.65 | 0.57 | 0.54 |
| Cash Conversion Cycle | 208.11 | 174.20 | 195.81 | 207.53 |